$10.67
1.81% today
Nasdaq, Feb 05, 07:48 pm CET
ISIN
US21900C3088
Symbol
CRMD

CorMedix Inc Target price 2025 - Analyst rating & recommendation

CorMedix Inc Classifications & Recommendation:

Buy
100%

CorMedix Inc Price Target

Target Price $16.83
Price $10.48
Potential
Number of Estimates 6
6 Analysts have issued a price target CorMedix Inc 2026 . The average CorMedix Inc target price is $16.83. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend CorMedix Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CorMedix Inc stock has an average upside potential 2026 of . Most analysts recommend the CorMedix Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.00 39.55
100.00%

6 Analysts have issued a sales forecast CorMedix Inc 2024 . The average CorMedix Inc sales estimate is

$39.6m
Unlock
. This is
222.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$43.4m 254.00%
Unlock
, the lowest is
$31.5m 157.26%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $0.0 100.00%
2025
$126m 218.96%
Unlock
2026
$161m 27.99%
Unlock
2027
$239m 47.78%
Unlock
2028
$330m 38.39%
Unlock

1 Analyst has issued a net profit forecast CorMedix Inc 2024 . The average CorMedix Inc net profit estimate is

$-23.7m
Unlock
. This is
48.76% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-23.7m 48.76%
Unlock
, the lowest is
$-23.7m 48.76%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-52.7m 22.97%
2024
$-23.7m 54.95%
Unlock
2025
$19.7m 182.93%
Unlock
2026
$45.2m 129.42%
Unlock
2027
$115m 155.15%
Unlock
2028
$177m 53.26%
Unlock

Net Margin

2025
15.60% 126.00%
Unlock
2026
27.97% 79.29%
Unlock
2027
48.28% 72.61%
Unlock
2028
53.47% 10.75%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -0.91 -0.41
22.97% 54.95%
P/E negative
EV/Sales 14.93

1 Analysts have issued a CorMedix Inc forecast for earnings per share. The average CorMedix Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.41
Unlock
. This is
48.75% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.41 48.75%
Unlock
, the lowest is
$-0.41 48.75%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.91 22.97%
2024
$-0.41 54.95%
Unlock
2025
$0.34 182.93%
Unlock
2026
$0.78 129.41%
Unlock
2027
$1.99 155.13%
Unlock
2028
$3.05 53.27%
Unlock

P/E ratio

Current -13.08 261.33%
2024
-25.56 95.41%
Unlock
2025
30.82 220.58%
Unlock
2026
13.44 56.39%
Unlock
2027
5.27 60.79%
Unlock
2028
3.44 34.72%
Unlock

Based on analysts' sales estimates for 2024, the CorMedix Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

14.93
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
16.08
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 48.16 98.28%
2024
14.93 69.00%
Unlock
2025
4.68 68.65%
Unlock
2026
3.66 21.87%
Unlock
2027
2.47 32.33%
Unlock
2028
1.79 27.74%
Unlock

P/S ratio

Current 51.87 99.08%
2024
16.08 69.00%
Unlock
2025
5.04 68.65%
Unlock
2026
3.94 21.87%
Unlock
2027
2.67 32.33%
Unlock
2028
1.93 27.74%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today